AI assistant
STRIDES PHARMA SCIENCE LIMITED — Board/Management Information 2023
Oct 30, 2023
62616_rns_2023-10-30_a5df6efd-9799-4a39-b90a-1144180e7db3.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [128 x 42] intentionally omitted <==
October 30, 2023
BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001
Scrip code: 532531
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051
Scrip code: STAR
Dear Madam/ Sir,
Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/ HO/ CFD/ CFDPoD-1/ P/ CIR/ 2023/ 123 dated July 13, 2023
With reference to the above, we wish to inform you about the following change in Senior Management Personnel (SMP) of the Company:
-
1) Resignation of Mr. Christoph Funke, Chief Operating Officer of the Company effective February 29, 2024;
-
2) Appointment of Mr. Ramaraju PVS as the Chief Operating Officer of the Company effective March 1, 2024.
Ram will join the rolls of Strides effective November 1, 2023 and will work with Christoph to transition his role during the next 4 months.
Letter of resignation from Mr. Christoph Funke along with disclosures in the prescribed format is enclosed as an Annexure to this letter.
This is for your information and records.
Thanks & Regards, For Strides Pharma Science Limited,
MANJULA Digitally signed by MANJULA RAMAMURT RAMAMURTHY Date: 2023.10.30 HY 14:47:38 +05'30' Manjula Ramamurthy Company Secretary ICSI Membership No. A30515
Encl. As above
==> picture [479 x 53] intentionally omitted <==
==> picture [128 x 42] intentionally omitted <==
Annexure A
Resignation of Mr. Christoph Funke, Chief Operating Officer (COO) of the Company effective February 29, 2024
| # | Details | Information of such event | |
|---|---|---|---|
| 1. | Reasons for change, viz., ~~appointment,~~resignation, ~~removal, death or otherwise~~ |
Resignation of Mr. Christoph Funke as COO of the Company. | |
| 2. | Date of~~appointment/ re-~~ ~~appointment/~~cessation~~and~~ ~~term of appointment/ re-~~ ~~appointment~~ |
Resignation is effective closing business hours of February 29, 2024. |
|
| 3. | Brief profile (in case of appointment) |
Not Applicable | |
| 4. | Disclosure of relationships between directors (in case of appointment of a director) |
Not Applicable |
==> picture [479 x 53] intentionally omitted <==
Annexure B
==> picture [128 x 42] intentionally omitted <==
Appointment of Mr. PVS Ramaraju as Chief Operating Officer (COO) of the Company effective March 1, 2024
| # | Details | Information of such event | ||
|---|---|---|---|---|
| 1. | Reasons for change, viz., appointment~~, resignation,~~ ~~removal, death or otherwise~~ |
Appointment of Mr. Ramaraju PVS (Ram) as the COO of the Company effective March 1, 2024. |
||
| 2. | Date of appointment~~/ re-~~ ~~appointment/ cessation~~and term of appointment~~/ re-~~ ~~appointment~~ |
Ram will join the rolls of Strides effective November 1, 2023 and will work with Christoph to transition his role during the next four months. |
||
| 3. | Brief profile (in case of appointment) |
Ram has served in multiple leadership capacities in Strides Pharma and later with Stelis Biopharma, primarily focusing on quality and manufacturing Operations. With thirty years of pharmaceutical industry experience, he has dedicated over sixteen years to the Strides Group, demonstrating a long-term commitment and amassing a wealth of industry knowledge. Throughout his illustrious career, he has also been associated with reputable organizations like Dr. Reddy’s, USV and Unichem. Ram is a post-graduate in Pharmaceutical Chemistry from BITS Pilani. |
||
| 4. | Disclosure of relationships between directors (in case of appointment of a director) |
Not Applicable |
==> picture [479 x 53] intentionally omitted <==
From: Christoph Funke Christoph.Funke@strides.com Sent: 23 September 2023 00:01
To: Arun Kumar arun@strides.com Subject: CONFIDENTIAL
Dear Arun,
I am herewith tendering my resignation from my role as Chief Operations Officer at Strides Pharma Science Limited.
My last day of work will be during February 2024 as discussed earlier.
I am truly grateful for the opportunity you personally and the company have given me.
During my notice period, I will continue to support the business with my undivided focus and energy.
I wish you and the business success in the future.
Christoph
1